Gujarat Inject P/B Ratio
Gujarat Inject (GUJINJEC) P/B ratio is 4.75 (High), book value per share ₹6.67 vs Healthcare average P/B of -0.67 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see GUJINJEC share price screener.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
GUJINJEC P/B Ratio — Valuation Insights & Book Value Analysis
Gujarat Inject price-to-book ratio interpretation, valuation status and historical context — current P/B 4.75 (High). View Gujarat Inject 52-week for the annual high/low range and current price position.
- Stock appears overvalued with PB of 4.75, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.67
Gujarat Inject P/B Ratio Historical Trend
GUJINJEC annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with GUJINJEC fair price to assess whether the stock is under or overvalued.
GUJINJEC Historical P/B Ratio — Book Value Per Share & Year-End Price
Gujarat Inject annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 5.36 | ₹6.67 | ₹35.75 | ₹10 | High |
| 2024 | 3.1 | ₹8.18 | ₹25.39 | ₹9 | High |
GUJINJEC vs Healthcare Peers — P/B Ratio Comparison
Gujarat Inject P/B 4.75 vs Healthcare average -0.67, median 0.6 — range -17.92–1.01.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -17.92 | ₹22 | Low |
| Sun Pharma Advanced Rese… | SPARC | -16.05 | ₹5,310 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.32 | ₹76 | Low |
| Parmax Pharma | PARMAX | -2.16 | ₹12 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹127 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |